Anti-tuberculosis treatment and infliximab [4]

Respiratory Medicine

Volumn 99, Issue 12, 2005, Pages 1620-1622

  Wallis, Robert S ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BRONCHOSCOPY; DISEASE COURSE; DRUG INFUSION; DRUG PENETRATION; EXTRAPULMONARY TUBERCULOSIS; GENE EXPRESSION; GRANULOMA; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTERMETHOD COMPARISON; LETTER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METHODOLOGY; MILIARY TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT WITHDRAWAL; TUBERCULIN TEST; TUBERCULOSIS; VIRUS LOAD;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; HUMANS; IMMUNOTHERAPY; RECURRENCE; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28044451340     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.06.010     Document Type: Letter

References (27)

1. E. Vlachaki K. Psathakis K. Tsintiris A. Iliopoulos Delayed response to anti-tuberculosis treatment in a patient on infliximab Respir Med 99 2005 648-652
2. J.W. Chien J.L. Johnson Paradoxical reactions in HIV and pulmonary TB Chest 114 1998 933-936
3. M. Narita D. Ashkin E.S. Hollender A.E. Pitchenik Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS Am J Respir Crit Care Med 158 1998 157-161
4. E. Navas P. Martin-Davila L. Moreno V. Pintado J.L. Casado J. Fortun et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy Arch Intern Med 162 2002 97-99
5. D. Orlovic R.A. Smego Jr Paradoxical tuberculous reactions in HIV-infected patients Int J Tuberc Lung Dis 5 2001 370-375
6. A. Wanchu A. Sud P. Bambery S. Singh Paradoxical reaction in HIV and tuberculosis coinfection J Assoc Physicians India 50 2002 588-589
7. K.A. Wendel K.S. Alwood R. Gachuhi R.E. Chaisson W.R. Bishai T.R. Sterling Paradoxical worsening of tuberculosis in HIV-infected persons Chest 120 2001 193-197
8. C.R. Hawkey T. Yap J. Pereira D.A. Moore R.N. Davidson G. Pasvol et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis Clin Infect Dis 40 2005 1368-1371
9. R. Teoh M.J. Humphries G. O'Mahony Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: A report of 10 patients and review of the literature Q J Med 63 1987 449-460
10. E.J. Carter S. Mates Sudden enlargement of a deep cervical lymph node during and after treatment for pulmonary tuberculosis Chest 106 1994 1896-1898
11. G. Breton X. Duval C. Estellat X. Poaletti D. Bonnet M.D. Mvondo et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy Clin Infect Dis 39 2004 1709-1712
12. Wallis RS, Saliu OY, Sofer C, Stein DS, Schwander SK. Effect of TNF blockers on expression of mycobacterial immunity in vitro. In: International Conference on the Pathogenesis of Mycobacterial Infections, 2005. p. 6.
13. J. Zou M. Rudwaleit J. Brandt A. Thiel J. Braun J. Sieper Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept Ann Rheum Dis 62 2003 561-564
14. M.A. Gardam E.C. Keystone R. Menzies S. Manners E. Skamene R. Long et al. Anti-tumour necrosis factor agents and tuberculosis risk: Mechanisms of action and clinical management Lancet Infect Dis 3 2003 148-155
15. R.S. Wallis M.S. Broder J.Y. Wong D.O. Beenhouwer Granulomatous infections due to tumor necrosis factor blockade: Correction Clin Infect Dis 39 2004 1254-1256
16. R.S. Wallis M. Broder J. Wong A. Lee L. Hoq Reactivation of latent granulomatous infections by infliximab Clin Infect Dis 41 2005 S194-S198
17. C. Garcia Vidal S.R. Fernandez J.M. Lacasa M. Salavert M.R. Carballeira J. Garau Paradoxical response to anti-tuberculous therapy in infliximab-treated patients with disseminated tuberculosis Clin Infect Dis 40 2005 756-759
18. P.C. Karakousis T. Yoshimatsu G. Lamichhane S.C. Woolwine E.L. Nuermberger J. Grosset et al. Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice J Exp Med 200 2004 647-657
19. R.S. Wallis Reconsidering adjuvant immunotherapy for tuberculosis Clin Infect Dis 41 2005 201-208
20. J. Dhillon D.A. Mitchison Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig Br J Exp Pathol 70 1989 103-110
21. R.S. Wallis H.Y. Song C. Whalen A. Okwera TB chemotherapy: Antagonism between immunity and sterilization Am J Respir Crit Care Med 169 2004 771-772
22. J.L. Johnson E. Ssekasanvu A. Okwera H. Mayanja C.S. Hirsch J.G. Nakibali et al. Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis Am J Respir Crit Care Med 168 2003 185-191
23. R.S. Wallis P. Kyambadde J.L. Johnson L. Horter R. Kittle M. Pohle et al. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis AIDS 18 2004 257-264
24. H. Mayanja-Kizza E.C. Jones-Lopez A. Okwera R.S. Wallis J.J. Ellner R.D. Mugerwa et al. Immunoadjuvant therapy for HIV-associated tuberculosis with prednisolone: A phase II clinical trial in Uganda J Infect Dis 191 2005 856-865
25. P. Sonnenberg J. Murray J.R. Glynn S. Shearer B. Kambashi P. Godfrey-Faussett HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: A cohort study in South African mineworkers Lancet 358 2001 1687-1693
26. M. Weiner W. Burman A. Vernon K. Khan TB Trials Consortium Effect of HIV coinfection on two month sputum culture conversion and its associations with TB treatment outcomes Proc Am Thorac Soc 2A20 2005
27. W.M. el Sadr D.C. Perlman J.P. Matts E.T. Nelson D.L. Cohn N. Salomon et al. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG) Clin Infect Dis 26 1998 1148-1158